
    
      We are using depression symptom measurements and measurements of brain electrical activity
      (EEG) to determine what factors may influence whether a patient is likely to show a response
      to antidepressant medication, placebo, or only clinical visits (without the use of pills)
      during a treatment trial for depression.
    
  